- Home
- ACH vs SERA Comparison
ACH vs SERA Comparison
Compare ACH & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACH | SERA |
|---|---|---|
| Founded | 1882 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.4M | 75.2M |
| IPO Year | 2001 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACH | SERA |
|---|---|---|
| Price | $0.43 | $2.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $1.51 | ★ $5.50 |
| AVG Volume (30 Days) | ★ 1.3M | 16.1K |
| Earning Date | 10-29-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,762,032,000.00 | $81,000.00 |
| Revenue This Year | N/A | $177.78 |
| Revenue Next Year | $2.97 | $755.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $0.44 | $1.56 |
| 52 Week High | $4.69 | $3.95 |
Technical Indicators
Market Signals| Indicator | ACH | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 16.16 | 54.12 |
| Support Level | N/A | $1.94 |
| Resistance Level | $1.26 | $2.21 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 0.02 | 47.14 |
Price Performance
Historical ComparisonAbout ACH Accendra Health Inc.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.